This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/497715-azar-on-russian-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| ‘Safe & effective’ over ‘first’: US throws shade at Russia’s first-to-market Covid-19 vaccine | ‘Safe & effective’ over ‘first’: US throws shade at Russia’s first-to-market Covid-19 vaccine |
| (2 days later) | |
| Top US health officials insist they're holding out for a “safe and effective” Covid-19 vaccine, hinting that Russia’s shot is anything but – or even that it’s a plot to 'goad the US into forcing early action on our vaccines.' | Top US health officials insist they're holding out for a “safe and effective” Covid-19 vaccine, hinting that Russia’s shot is anything but – or even that it’s a plot to 'goad the US into forcing early action on our vaccines.' |
| “The point is not to be first with a vaccine, the point is to have a vaccine that is safe and effective for the American people and the people of the world,” US Secretary of Health and Human Services Alex Azar told ABC on Tuesday, demanding “transparent” phase-three test data. | “The point is not to be first with a vaccine, the point is to have a vaccine that is safe and effective for the American people and the people of the world,” US Secretary of Health and Human Services Alex Azar told ABC on Tuesday, demanding “transparent” phase-three test data. |
| Food and Drug Administration Commissioner Scott Gottlieb was more pointed in his criticism of Russia’s coronavirus jab, suggesting that “today’s news that they ‘approved’ a vaccine on the equivalent of phase-one data may be another effort to stoke doubts [in US vaccine development] or goad [the] US into forcing early action on our vaccines” in a Tuesday tweet. | Food and Drug Administration Commissioner Scott Gottlieb was more pointed in his criticism of Russia’s coronavirus jab, suggesting that “today’s news that they ‘approved’ a vaccine on the equivalent of phase-one data may be another effort to stoke doubts [in US vaccine development] or goad [the] US into forcing early action on our vaccines” in a Tuesday tweet. |
| The irony of US health officials criticizing the speed of Russia’s vaccine development appeared lost on the pair. The Trump administration’s own vaccine development program, called Operation Warp Speed, has been criticized even by the country’s most fervent vaccine boosters for its “unsafe” timeline, which has contracted from an ambitious 18-month projected schedule to “maybe before the election.” | The irony of US health officials criticizing the speed of Russia’s vaccine development appeared lost on the pair. The Trump administration’s own vaccine development program, called Operation Warp Speed, has been criticized even by the country’s most fervent vaccine boosters for its “unsafe” timeline, which has contracted from an ambitious 18-month projected schedule to “maybe before the election.” |
| The US and UK have both ordered millions of doses of a barely-tested, unproven vaccine developed by Oxford University in partnership with AstraZeneca, with HHS officials stating they hope to receive the first doses as early as October. While the shot has so far proven incapable of protecting monkeys from the virus, hope springs eternal. Another vaccine candidate, from newcomer Moderna, has triggered serious side effects in a large portion of test subjects but has nevertheless been hyped as a potential savior. The FDA hopes to approve a vaccine by December. | The US and UK have both ordered millions of doses of a barely-tested, unproven vaccine developed by Oxford University in partnership with AstraZeneca, with HHS officials stating they hope to receive the first doses as early as October. While the shot has so far proven incapable of protecting monkeys from the virus, hope springs eternal. Another vaccine candidate, from newcomer Moderna, has triggered serious side effects in a large portion of test subjects but has nevertheless been hyped as a potential savior. The FDA hopes to approve a vaccine by December. |
| Russia became the first country to grant regulatory approval to a vaccine for the novel coronavirus on Tuesday, as President Vladimir Putin announced that the formula developed at the state-run Gamaleya Research Institute had “passed all the needed checks” and was ready to be distributed to health workers. | |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |